Global Transcatheter Heart Valve Market is Expected to be Worth US$ 7,642.7 Million, by The End of 2027

Transcatheter Heart Valve
Transcatheter Heart Valve


Transcatheter heart valve implantation is a minimally invasive procedure that involves replacing damaged heart valves with bioprosthetic valves to treat valvular heart disease (VHD), such as aortic stenosis and mitral regurgitation. It's a less invasive alternative to open heart surgery, and it's especially beneficial for patients who are at extremely high risk. Furthermore, increasing technological advancements in surgical procedures are driving up demand for Transcatheter Heart Valve Market. The industry is growing due to an increase in the incidence of valvular heart disease around the world, as well as a growing demand for less invasive procedures. The rising number of geriatrics with heart valve diseases is leading to an increase in valve replacement surgeries.  Furthermore, the market revenue is being boosted by a favourable reimbursement scenario and growing manufacturer interest.

The rising prevalence of VHD is expected to propel the global Transcatheter Heart Valve Market forward during the forecast period. According to the study 'Epidemiology and Trends of Aortic Stenosis Mortality in the United States (1999-2016)' published in the Journal of the American College of Cardiology in March 2019, aortic stenosis is linked to a mortality rate of 106.3 per 1 million people, with non-Hispanic whites having the highest mortality rate, followed by Hispanics, and non-Hispanic blacks. Furthermore, there was an increase in age-adjusted mortality between the two periods, according to the study.

The global Transcatheter Heart Valve Market is expected to be hampered by the high cost of transcatheter heart valves. Transcatheter aortic valve replacement (TAVR) devices, for example, cost US$ 32,000 on average, compared to US$ 4,000–US$ 7,000 for surgical aortic valve replacement (SAVR) devices.

Furthermore, TAVR is linked to a number of risks and complications, including artery damage from catheter insertion, which can result in major bleeding, valve leakage, infection, kidney failure, heart attack, major stroke, and death during the procedure. As a result, market growth is expected to be aided by the growing geriatric population. According to the World Health Organization, the geriatric population is expected to increase from 900 million to 2 billion by 2050.

Comments

Popular posts from this blog

Security Robot Market to Reach US$ 11.8 Billion by 2022

Intravenous Fluid Therapy is the Fastest Growing Segment Fueling the Growth of Intravenous Solutions Market

Global Report on LED Driver Market for the Forecast Period 2023-2030